"Treatment for substance use disorders is designed to help people stop alcohol or drug use and remain sober and drug free. Substance use disorders affect every part of a person’s life. For that reason, treatment needs to affect every part of a person’s life as well. Treatment involves more than helping someone stop drinking alcohol or using drugs." - Substance Abuse and Mental Health Services Administration
LEVELS OF CLINICAL CARE
The levels of clinical care delineate a continuum of clinical addiction treatment services, increasing in intensity from level 1 to level 4.
Each level of care refers to a broad category of services and treatment formats offered to patients.
A professionally delivered treatment modality that provides daily to weekly attendance at a clinic or facility, typically less than 9 hours of service/week for adults, or less than 6 hours a week for adolescents, allowing the patient to return home or to other living arrangements during non-treatment hours.
- Recovery Research Institute
Recruit, train, and mentor interdisciplinary teams of SUD/OUD clinical and social service providers who are trained, certified, and willing to provide medication-assisted treatment (MAT), evidence-based behavioral therapy, and FDA-approved pharmacotherapy.
Pharmacotherapy (pharmacology) is the treatment of a disorder or disease with medication, which can be used at any level of clinical care.
In the treatment of addiction, medications are used to reduce the intensity of withdrawal symptoms, reduce alcohol and other drug cravings, and reduce the likelihood of use or relapse for specific drugs by blocking their effect. The primary goal of medication-assisted treatment is for the patient to achieve fully sustained remission.
Medication-assisted treatment (MAT), including opioid treatment programs (OTPs), combines behavioral therapy and medications to treat substance use disorders (see agonist; antagonist).
MEDICATIONS FOR OPIOID USE DISORDER - Recovery Research Institute